Research integrates metabolomics, network pharmacology, and multi-tier biological assays to evaluate natural products and small molecules. We interrogate oxidative stress, inflammation, and cell survival pathways to progress preclinical candidates for gastrointestinal, wound, neuroprotective, and oncology indications.